SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0269881106073219v1
21/1/10    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (19)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Nutt, D. J.
Right arrow Articles by Young, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nutt, D. J.
Right arrow Articles by Young, S.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Attention Deficit Hyperactivity Disorder
*Teen Health
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology

D. J. Nutt

Psychopharmacology Unit, University of Bristol, Bristol, UK, david.j.nutt{at}bristol.ac.uk

K. Fone

University of Nottingham, Nottingham UK

P. Asherson

MRC Social Genetic Developmental Psychiatry, Institute of Psychiatry, King’s College London, UK

D. Bramble

Telford & Wrekin PCT, Shrewsbury, UK

P. Hill

London, UK

K. Matthews

University of Dundee, Dundee UK

K. A. Morris

Psychopharmacology Unit, University of Bristol, Bristol, UK

P. Santosh

Institute of Psychiatry, London, UK

E. Sonuga-Barke

University of Southampton, Southampton, UK

E. Taylor

Institute of Psychiatry, London, UK

M. Weiss

University of British Columbia, Vancouver, Canada

S. Young

Bethlem Royal Hospital, Kent, UK

Attention-deficit/hyperactivity disorder (ADHD) is an established diagnosis in children, associated with a large body of evidence on the benefits of treatment. Adolescents with ADHD are now leaving children’s services often with no readily identifiable adult service to support them, which presents problems as local pharmacy regulations often preclude the prescription of stimulant drugs by general practitioners (GPs). In addition, adults with ADHD symptoms are now starting to present to primary care and psychiatry services requesting assessment and treatment. For these reasons, the British Association for Psychopharmacology (BAP) thought it timely to hold a consensus conference to review the body of evidence on childhood ADHD and the growing literature on ADHD in older age groups. Much of this initial guidance on managing ADHD in adolescents in transition and in adults is based on expert opinion derived from childhood evidence. We hope that, by the time these guidelines are updated, much evidence will be available to address the many directions for future research that are detailed here.

Key Words: ADHD • hyperkinetic disorders • hyperactivity • impulsivity • psychostimulants • psychotherapy • co-morbidities

This version was published on January 1, 2007

Journal of Psychopharmacology, Vol. 21, No. 1, 10-41 (2007)
DOI: 10.1177/0269881106073219


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
M Koesters, T Becker, R Kilian, J. Fegert, and S Weinmann
Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder
J Psychopharmacol, September 1, 2009; 23(7): 733 - 744.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
J Godfrey
Safety of therapeutic methylphenidate in adults: a systematic review of the evidence
J Psychopharmacol, March 1, 2009; 23(2): 194 - 205.
[Abstract] [PDF]


Home page
The PsychiatristHome page
A. A. Ahmed, S. Cress, and L. Lovett
Adult ADHD: the new kid on the block has grown up
The Psychiatrist, January 1, 2009; 33(1): 37 - 37.
[Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
G Akram, A H Thomson, A C Boyter, and M J S Morton
Characterisation and evaluation of UK websites on attention deficit hyperactivity disorder
Arch. Dis. Child., August 1, 2008; 93(8): 695 - 700.
[Abstract] [Full Text] [PDF]


Home page
J Atten DisordHome page
M. Weiss, S. A. Safren, M. V. Solanto, L. Hechtman, A. L. Rostain, J. R. Ramsay, and C. Murray
Research Forum on Psychological Treatment of Adults With ADHD
J Atten Disord, May 1, 2008; 11(6): 642 - 651.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
J. Verster and D. Cox
ADHD, methylphenidate and driving: does some legislation endanger public health?
J Psychopharmacol, May 1, 2008; 22(3): 227 - 229.
[PDF]



Advertisement